Human genome mapping and sequencing: perspectives for toxicology.
Until recently, the human genome programs were mainly directed towards the development of maps to identify disease genes. Three major tools: the genetic map, the physical map and the gene map are presently available. The human genome project is now progressively shifting to massive sequencing although sequence-ready maps are not yet available for a large part of the human genome. In addition, our capacity to interpret the available genomic sequence remains limited. Despite these drawbacks, the existing genetic map can be used to localize susceptibility factors to toxic agents, as recently exemplified for the mouse. The available tools or others to be developed in the near future can open the way to new approaches in toxicology.